Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
Value of Quantitative Sensory Testing in the Evaluation of Genital Sensation: Its Application to Female Sexual Dysfunction.
Disease modifying therapies for relapsing multiple sclerosis.
Relevance of biomarkers in disease progression in multiple sclerosis.
Performance of F2 B6x129 hybrid mice in the Morris water maze, latent inhibition and prepulse inhibition paradigms: Comparison with C57Bl/6J and 129sv inbred mice.
Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
Effects of chlorogenic acid on adenine nucleotides hydrolyzing enzyme activities and expression in platelets of rats experimentally demyelinated with ethidium bromide.
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses.
Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.
Oligodendrocyte differentiation.
Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis.
Understanding the Impact of Brain Disorders: Towards a 'Horizontal Epidemiology' of Psychosocial Difficulties and Their Determinants.
Neuroinflammatory paradigms in lysosomal storage diseases.
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
[Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
An update on the causes, assessment and management of third division sensory trigeminal neuropathies.
CADASIL and multiple sclerosis: A case report of prolonged misdiagnosis.
Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica.
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.
Arzerra receives approval in Japan
Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2).
Four-dimensional flow magnetic resonance imaging and ultrasound assessment of cerebrospinal venous flow in multiple sclerosis patients and controls.
Neuromyelitis optica accompanied by nephrotic syndrome and autoimmune-related pancytopenia.
Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism.

Pages